GSM
Genetic surveillance of malaria parasites in Ghana to monitor antimalarial drug resistance and inform national control strategies. The Genetic Surveillance of Malaria (GSM) project prospectively collected clinical samples across thirty (30) health facilities across the administrative regions of Ghana from 2019 to 2023. Samples were genotyped for key drug resistance marker including kelch13, pfmdr1, pfcrt, dhfr, and dhps.